Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Christina P. Opperman"'
Publikováno v:
Journal of Innovation Management, Vol 9, Iss 4, Pp 98-126 (2022)
This article aims to explore the impact of emotions and behaviours of innovation champions on organisation innovation outcomes. Our research suggests that champions do not necessarily contribute to successful outcomes. This could be ascribed to the f
Externí odkaz:
https://doaj.org/article/2c5bd77b5e3a4c6586423a6e2bc8ceef
Publikováno v:
SA Journal of Human Resource Management, Vol 19, Iss 0, Pp e1-e5 (2021)
No abstract available.
Externí odkaz:
https://doaj.org/article/96e969679d9f49e0a08d9903bd255012
Autor:
Kathleen N. Moore, Alexandra Leary, Dominique Berton, Christina P. Opperman, Maria Del Pilar Estevez-Diz, Laurence Gladieff, Marek Ancukiewicz, Anne-Claire Hardy-Bessard, Frédéric Selle, Isabelle Ray-Coquard, Waldo Ortuzar Feliu, Carlos Rojas, Bradley J. Monk, David M. O'Malley, Ana Oaknin, Carla Rameri Alexandre Silva de Azevedo, Leslie M Randall, Jérôme Alexandre
Publikováno v:
Scientia
Cervical cancer; Checkpoint inhibitor; Immunotherapy Cáncer de cuello uterino; Inhibidor de puntos de control; Inmunoterapia Càncer cervical; Inhibidor de punts de control; Immunoteràpia Objective This phase II clinical trial evaluated the safety
Autor:
Qing Yuan Zhang, Tao Sun, Yong Mei Yin, Hui Ping Li, Min Yan, Zhong Sheng Tong, Christina P. Oppermann, Yun Peng Liu, Romulo Costa, Man Li, Ying Cheng, Qu Chang Ouyang, Xi Chen, Ning Liao, Xin Hong Wu, Xiao Jia Wang, Ji Feng Feng, Roberto Hegg, G.B. Kanakasetty, Maria A. Coccia-Portugal, Ru Bing Han, Yi Lu, Hai Dong Chi, Ze Fei Jiang, Xi Chun Hu
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 12 (2020)
Aim: To compare the efficacy, safety, and tolerability of abemaciclib plus endocrine therapy (ET) versus ET alone in postmenopausal women with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced breast ca
Externí odkaz:
https://doaj.org/article/97a1aeef27ca442790bae5374547f9e7